Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Biomarin Pharmaceutical Inc Transaction History

Meag Munich Ergo, Kapitalanlagegesellschaft Mb H

  • $2.7 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 25, 2022
SELL
$71.72 - $91.47 $359,890 - $458,996
-5,018 Closed
0 $0
Q2 2021

Jul 16, 2021
SELL
$75.51 - $84.79 $13,969 - $15,686
-185 Reduced 3.56%
5,018 $419,000
Q1 2021

Apr 20, 2021
BUY
$74.73 - $90.69 $388,820 - $471,860
5,203 New
5,203 $393,000

Others Institutions Holding BMRN

# of Institutions
623
Shares Held
181M
Call Options Held
1.73M
Put Options Held
1.73M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $15.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Meag Munich Ergo, Kapitalanlagegesellschaft Mb H Portfolio

Follow Meag Munich Ergo, Kapitalanlagegesellschaft Mb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meag Munich Ergo, Kapitalanlagegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Meag Munich Ergo, Kapitalanlagegesellschaft Mb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email